Analyst Price Target is $103.00
▲ +7.85% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Addus HomeCare in the last 3 months. The average price target is $103.00, with a high forecast of $118.00 and a low forecast of $83.00. The average price target represents a 7.85% upside from the last price of $95.50.
Current Consensus is
Moderate Buy
The current consensus among 7 contributing investment analysts is to moderate buy stock in Addus HomeCare. This Moderate Buy consensus rating has held steady for over two years.
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Read More
